Similar phenomena were also observed in patients with CLL, whose mo-DC expressed reduced levels of important molecules involved in antigen presentation and lymphocyte activation, such as HLA-DR, CD80, CD86, CD83, and CD40, and, coherently, were less effective in inducing proliferation of both CD4+ and CD8+ T cells. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.